Question to the Department of Health and Social Care:

To ask Her Majesty’s Government what alternative pricing and reimbursement arrangements they are considering for newly launched or soon-to-be launched antibiotics in advance of the independent antimicrobial resistance review.

The Department is in the process of convening a group involving industry to explore how to address interim issues pending the conclusion of the review on antimicrobial resistance. Among these will be the pricing and reimbursement of new antimicrobial products.